I believe this premium is the difference between actual value vs what the buyer would pay at the time. So in this case it's actually the discount to NAV; could also consider it a time value of money/risk based discount.
If we have a SP of 10c near end of 2013, and NAV of 20c at that time for example, and the buyer offers 15c per share, most SH would probably be happy to sell.
This is a likely scenario once all permits are in hand, and all finance arrangements are locked in. I'm thinking end 2013 or early 2014.
There will certainly be suitors, of that I have no doubt.
- Forums
- ASX - By Stock
- PEN
- Ann: Broker Research Report
Ann: Broker Research Report , page-5
Featured News
Add PEN (ASX) to my watchlist
(20min delay)
|
|||||
Last
6.2¢ |
Change
-0.021(25.3%) |
Mkt cap ! $197.6M |
Open | High | Low | Value | Volume |
7.6¢ | 7.6¢ | 6.1¢ | $8.401M | 126.7M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
29 | 2735758 | 6.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.3¢ | 494493 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
21 | 2490861 | 0.061 |
26 | 3014378 | 0.060 |
11 | 839551 | 0.059 |
6 | 2263059 | 0.058 |
3 | 90800 | 0.057 |
Price($) | Vol. | No. |
---|---|---|
0.063 | 113635 | 3 |
0.064 | 570000 | 5 |
0.065 | 1252967 | 7 |
0.066 | 220000 | 2 |
0.067 | 323253 | 3 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
PEN (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online